Abstract

Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non–Small Cell Lung Cancer: A Predictive Marker of Efficacy?
Edouard Auclin ... Benjamin Besse
Journal of Thoracic Oncology | VOL. 14
Edouard Auclin, et. al.Edouard Auclin ... Benjamin Besse
23 Apr 2019
Abstract 4894: Incidence of high tumor mutation burden (TMB) and PD-L1 positivity in breast cancers and potential response to immune checkpoint inhibitors (ICPIs)
Ethan Sokol ... Saranya Chumsri
Cancer Research | VOL. 79
Ethan Sokol, et. al.Ethan Sokol ... Saranya Chumsri
01 Jul 2019
A lung squamous cell carcinoma-associated membranous nephropathy patient free of tumor and membranous nephropathy after the treatment of surgery and radiochemotherapy following pembrolizumab: A rare case report.
Haiwei Du ... Surong Fang
Medicine | VOL. 102
Haiwei Du, et. al.Haiwei Du ... Surong Fang
20 Jan 2023
Plasma cell free PD-L1 RNA expression correlated with tissue PD-L1 immunohistochemical staining and tumor mutation burden in non-small cell lung cancer.
Paul R Walker ... Nitika Sharma
Journal of Clinical Oncology | VOL. 38
Paul R Walker, et. al.Paul R Walker ... Nitika Sharma
20 May 2020
View more papers

More From: Chinese medical journal

Paper Title
Journal
Date
Author
C/EBPβ-Lin28a positive feedback loop triggered by C/EBPβ hypomethylation enhances the proliferation and migration of vascular smooth muscle cells in restenosis.
Xiaojun Zhou ... Lin Liao
Chinese medical journal | VOL. -
Xiaojun Zhou, et. al.Xiaojun Zhou ... Lin Liao
28 May 2024
Iron deposition in subcortical nuclei of Parkinson's disease: A meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies.
Jianing Jin ... Tao Feng
Chinese medical journal | VOL. -
Jianing Jin, et. al.Jianing Jin ... Tao Feng
28 May 2024
Role of triggering receptor expressed on myeloid cells-1 in kidney diseases: A biomarker and potential therapeutic target.
Yuxi Fan ... Helong Dai
Chinese medical journal | VOL. -
Yuxi Fan, et. al.Yuxi Fan ... Helong Dai
28 May 2024
Global burden of non-communicable diseases attributable to kidney dysfunction with projection into 2040.
Jing Chen ... Xiaoxi Zeng
Chinese medical journal | VOL. -
Jing Chen, et. al.Jing Chen ... Xiaoxi Zeng
28 May 2024
View more papers